News

Vanda Pharmaceuticals Set for Major Investor Conferences Soon

Vanda Pharmaceuticals Set for Major Investor Conferences Soon

Vanda Pharmaceuticals: Upcoming Investor Engagements

Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) has announced its participation in several pivotal investor conferences scheduled for September 2025. These gatherings present an excellent opportunity for the company to showcase its innovative approaches and connect with investors.

Details of the Scheduled Conferences

The first event on the agenda is the Cantor Global Healthcare Conference 2025, taking place in New York City. Vanda is set to deliver a corporate presentation on this occasion. Attendees can look forward to insights from the company at 3:55 p.m. Eastern Time on September 3, 2025.

Wells Fargo Healthcare Conference

Subsequently, Vanda will participate in the 2025 Wells Fargo Healthcare Conference in Boston, where it will present to investors on September 4, 2025, at 4:30 p.m. Eastern Time. This conference serves as another important platform for Vanda to discuss its pipeline and strategic focus.

H.C. Wainwright Global Investment Conference

On September 9, 2025, Vanda will continue its investor outreach at the H.C. Wainwright Annual Global Investment Conference, once again taking place in New York City. The presentation is scheduled for 8:30 a.m. Eastern Time, offering investors valuable information about the company's future direction and advancements.

Accessing Presentations Online

For those unable to attend in person, Vanda's corporate presentations at the Cantor, Wells Fargo, and H.C. Wainwright conferences will be accessible live on Vanda’s corporate website. Investors should navigate to the Investors tab and follow the link under Recent Events. It is recommended that they log on at least 15 minutes prior to the start time to ensure all necessary software is installed and any issues are resolved. Following the conferences, an archived version of the presentations will be available on the website for about 30 days.

About Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc. is a prominent player in the biotechnology sector, focused on developing innovative therapies that address significant unmet medical needs. The company is committed to improving the quality of life for patients by providing solutions through its comprehensive product development pipeline. Vanda's efforts emphasize the importance of research and development in delivering effective treatments to the market.

Furthermore, as part of its outreach, Vanda encourages interested parties to visit their official website for updates and further information on their initiatives. Following Vanda on social media also provides stakeholders with regular insights and news from the company.

Corporate Contact Information

For additional inquiries, Vanda Pharmaceuticals can be contacted through the following representatives:

Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
Phone: 202-734-3400

Jim Golden, Jack Kelleher, Dan Moore
Collected Strategies

Frequently Asked Questions

What is Vanda Pharmaceuticals focused on?

Vanda Pharmaceuticals is dedicated to developing innovative therapies that address significant unmet medical needs.

When will Vanda participate in the Cantor Global Healthcare Conference?

Vanda's presentation at the Cantor Global Healthcare Conference is scheduled for September 3, 2025.

How can I access the corporate presentations online?

Investors can access the presentations live via Vanda's corporate website under the Investors tab and Recent Events section.

Are there any other conferences Vanda will attend?

Yes, Vanda will also be presenting at the Wells Fargo Healthcare Conference and the H.C. Wainwright Annual Global Investment Conference in September 2025.

Who should I contact for more information about Vanda?

For inquiries, you can reach out to Kevin Moran, Senior VP and CFO at Vanda Pharmaceuticals.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Lifeway Foods Set to Announce Q3 2026 Financial Results

Updated Category News Views 55

Anticipating Lifeway Foods’ Q3 Results Dust off your calendars and mark November 12, 2026—because that's when Lifeway Foods is putting its cards on the table for the third quarter. Nothing like a results call to see if your investments are eating right. NASDAQ:LWAY is no stranger to making some noise in the dairy aisle, thanks to their kefir—that fermented probiotic...

Continue Reading
LifeStance Expands Access to Esketamine, TMS

Updated Category News Views 53

LifeStance Health's Treatment Innovations Today, the spotlight is on LifeStance Health, as they're making waves with their treatment approaches for those battling stubborn, treatment-resistant depression. This isn't your run-of-the-mill attempt at tackling the beast—that familiar indifference masked as hope. No, this time around, they’re swinging with Esketamine and...

Continue Reading
CopperWood Senior Living Revives Historic Campus

Updated Category News Views 55

A Fresh Start for Peapack-Gladstone's Corporate Relic Dust off the pages of history—Peapack-Gladstone's old Pfizer/Beneficial Finance campus is getting a makeover, and boy, it’s not your run-of-the-mill renovation. We're talking adaptive reuse to the tune of nearly $200 million, morphing this architectural gem into CopperWood Senior Living. With all the office...

Continue Reading
Nicely Network: A Game-Changer for B2B SaaS Marketing

Updated Category News Views 173

Navigating the Reddit Marketing Labyrinth Life ain't a walk in the park for marketers these days, especially in the tech and SaaS arenas. Some folks seem to have cracked the code—or at least one part of it. Enter Nicely Network, which has just snagged the crown as the Best Reddit Marketing Agency for B2B SaaS & Software Companies, thanks to its knack for connecting...

Continue Reading
AI Literacy Framework Unfolds at AAC&U Conference

Updated Category News Views 30

Diverse Institutions Converge on AI Literacy A university conference isn't exactly where you'd expect seismic shifts, but this one's a bit of a dark horse. When big names like University of Phoenix, Boise State, Johns Hopkins, and the Medical University of South Carolina start syncing up their AI strategies, it feels like the sector's quietly brewing something big. At the...

Continue Reading
Hanwha's Big Bet: Tokenizing Real-World Assets with Chainlink

Updated Category News Views 15

Hanwha and Chainlink: A Game Changer in Tokenization What do Hanwha Investment & Securities, a heavyweight in Korea's finance scene, and Chainlink, the wizard of onchain finance, think they're up to? They're buddies now, locked and loaded, to tokenize real-world assets (RWAs). They're not just shaking hands; they're aiming to jiggle the global finance bedrock....

Continue Reading
Ruizhi Unveils Trio of High-Tech Paper Bag Machines

Updated Category News Views 21

Cutting-Edge Unveiling at All in Print China 2026 In the bustling expo halls of the Shanghai New International Expo Centre, Ruizhi Machinery rolled out the red carpet for its latest inventions, stealing the limelight at the All in Print China 2026. Now, these were not your run-of-the-mill paper bag makers; we're talking about a set of machines that could redefine the gig...

Continue Reading
Xerox Faces Probes After $130M Profit Forecast Slash

Updated Category News Views 45

When the Trust Breaks October 29, 2026 was a gut punch for Xerox investors. Watching the outlook dive by $130 million, the coffee-feeling in the trading rooms turned into something more bitter. A $105 million boost they once celebrated from tariff receivables now seems to be a fleeting shadow, as Xerox itself scuttles its adjusted operating income for 2026 to a range of...

Continue Reading
Tiny Fish Revolutionizes Vertebrate Gene Studies

Updated Category News Views 41

From Small Fish to Big Discoveries: Meet Danionella cerebrum Who would've thought a diminutive fish with a see-through body would give a jolt to the study of vertebrate genomes? Thanks to Danionella cerebrum, researchers at the Whitehead Institute have created the very first complete whole-body single-cell atlas of an adult vertebrate. Forget the Wall Street clamor for a...

Continue Reading
Instacart's Strong Q3 Amid DoorDash Acquisition News

Updated Category News Views 85

Bumper Profits and Bold Moves for Instacart Here's a twist in the grocery tech aisle—Instacart's got some hefty numbers rolling in for Q3 and a whopper of an acquisition announcement. What seemed like just another Tuesday in the market is shaken by Instacart's reveal of their third-quarter financial results, showcasing a significant year-over-year climb that would make...

Continue Reading

Top 5 Most Recently Viewed Articles

ASUR 4Q25 Earnings: Traffic Boost in Colombia, Mixed Signals

Updated Category News Views 165

Passenger Trends: A Bit of a Mixed Bag Traffic numbers can sometimes tell the real story, and for ASUR, it’s like reading a novel with plot twists. Colombia’s passenger traffic jumped 5.7%, fueled by robust international and domestic movements. Meanwhile, back in Puerto Rico? Things were not as rosy with a 3.1% drop due to lackluster domestic traffic. Mexico showed a...

Continue Reading
CVS Health's Unexpected Earnings Miss Sparks Analyst Optimism

Updated Category News Views 169

CVS Health Faces Challenges While Analysts Stay Positive Shares of CVS Health Corp (NYSE: CVS) have recently experienced a decline following the company’s preannouncement of a substantial earnings miss for the third quarter. This news comes during an exciting earnings season, generating considerable discussion among analysts and investors alike. Analyst Insights on CVS...

Continue Reading
Intercontinental Exchange Inc: Current Market Dynamics and Insights

Updated Category News Views 128

Understanding Intercontinental Exchange Inc's Market Position Intercontinental Exchange Inc (NYSE: ICE) has recently experienced a notable increase in short interest, which has risen by 8.59% since the last report. Currently, there are approximately 7.83 million shares that have been sold short, representing 1.39% of the total shares available for trading. Based on recent...

Continue Reading
Jason Passwaters: A Visionary Leader in Cybersecurity Innovation

Updated Category News Views 465

Jason Passwaters Receives Honorable Recognition Jason Passwaters, the dynamic CEO of Intel 471, has recently been celebrated for his significant contributions to the business world. His inclusion in the renowned Dallas 500 list acknowledges him as a pivotal figure among influential business leaders in the area. Passwaters’ Journey to Success With a strong foundation in...

Continue Reading
Investigation Launched into Greenwich LifeSciences, Inc.

Updated Category News Views 196

Investigation into Corporate Actions of Greenwich LifeSciences Greenwich LifeSciences, Inc. (NASDAQ: GLSI) finds itself under scrutiny as Purcell & Lefkowitz LLP initiates an investigation concerning potential breaches of fiduciary duties by the company’s directors. This investigation aims to address recent corporate actions that may not have aligned with the best...

Continue Reading